<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-id journal-id-type="pmc">plosone</journal-id>
    <journal-title-group>
      <journal-title>PLoS ONE</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5809007</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pone.0190134</article-id>
    <article-id pub-id-type="publisher-id">PONE-D-17-14461</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Biological Databases</subject>
            <subj-group>
              <subject>Sequence Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Bioinformatics</subject>
            <subj-group>
              <subject>Sequence Analysis</subject>
              <subj-group>
                <subject>Sequence Databases</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Database Searching</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pharmacology</subject>
          <subj-group>
            <subject>Routes of Administration</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Computational Techniques</subject>
          <subj-group>
            <subject>Split-Decomposition Method</subject>
            <subj-group>
              <subject>Multiple Alignment Calculation</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Database Searching</subject>
            <subj-group>
              <subject>Sequence Similarity Searching</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Bioinformatics</subject>
            <subj-group>
              <subject>Sequence Analysis</subject>
              <subj-group>
                <subject>Sequence Alignment</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Head</subject>
            <subj-group>
              <subject>Eyes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Head</subject>
            <subj-group>
              <subject>Eyes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Ocular System</subject>
            <subj-group>
              <subject>Eyes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Ocular System</subject>
            <subj-group>
              <subject>Eyes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Head</subject>
            <subj-group>
              <subject>Face</subject>
              <subj-group>
                <subject>Nose</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Head</subject>
            <subj-group>
              <subject>Face</subject>
              <subj-group>
                <subject>Nose</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TopicalPdb: A database of topically delivered peptides</article-title>
      <alt-title alt-title-type="running-head">TopicalPdb: A database of topically delivered peptides</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Mathur</surname>
          <given-names>Deepika</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <role content-type="http://credit.casrai.org/">Formal analysis</role>
        <role content-type="http://credit.casrai.org/">Investigation</role>
        <role content-type="http://credit.casrai.org/">Methodology</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <role content-type="http://credit.casrai.org/">Validation</role>
        <role content-type="http://credit.casrai.org/">Visualization</role>
        <role content-type="http://credit.casrai.org/">Writing – original draft</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Mehta</surname>
          <given-names>Ayesha</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Firmal</surname>
          <given-names>Priyanka</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Bedi</surname>
          <given-names>Gursimran</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sood</surname>
          <given-names>Charu</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data curation</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gautam</surname>
          <given-names>Ankur</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Writing – original draft</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8902-2876</contrib-id>
        <name>
          <surname>Raghava</surname>
          <given-names>Gajendra P. S.</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Formal analysis</role>
        <role content-type="http://credit.casrai.org/">Funding acquisition</role>
        <role content-type="http://credit.casrai.org/">Investigation</role>
        <role content-type="http://credit.casrai.org/">Project administration</role>
        <role content-type="http://credit.casrai.org/">Resources</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <role content-type="http://credit.casrai.org/">Supervision</role>
        <role content-type="http://credit.casrai.org/">Writing – original draft</role>
        <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="aff002">
          <sup>2</sup>
        </xref>
        <xref ref-type="corresp" rid="cor001">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh, India</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Gupta</surname>
          <given-names>Dinesh</given-names>
        </name>
        <role>Editor</role>
        <xref ref-type="aff" rid="edit1"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>International Centre for Genetic Engineering and Biotechnology, INDIA</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist. The corresponding author, Gajendra P. S. Raghava is a PLOS ONE Editorial Board member. This does not alter our adherence to PLOS ONE Editorial policies and criteria.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>raghava@imtech.res.in</email>, <email>raghava@iiitd.ac.in</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>12</day>
      <month>2</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2018</year>
    </pub-date>
    <volume>13</volume>
    <issue>2</issue>
    <elocation-id>e0190134</elocation-id>
    <history>
      <date date-type="received">
        <day>9</day>
        <month>5</month>
        <year>2017</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>12</month>
        <year>2017</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2018 Mathur et al</copyright-statement>
      <copyright-year>2018</copyright-year>
      <copyright-holder>Mathur et al</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pone.0190134.pdf"/>
    <abstract>
      <p>TopicalPdb (<ext-link ext-link-type="uri" xlink:href="http://crdd.osdd.net/raghava/topicalpdb/">http://crdd.osdd.net/raghava/topicalpdb/</ext-link>) is a repository of experimentally verified topically delivered peptides. Data was manually collected from research articles. The current release of TopicalPdb consists of 657 entries, which includes peptides delivered through the skin (462 entries), eye (173 entries), and nose (22 entries). Each entry provides comprehensive information related to these peptides like the source of origin, nature of peptide, length, N- and C-terminal modifications, mechanism of penetration, type of assays, cargo and biological properties of peptides, etc. In addition to natural peptides, TopicalPdb contains information of peptides having non-natural, chemically modified residues and D-amino acids. Besides this primary information, TopicalPdb stores predicted tertiary structures as well as peptide sequences in SMILE format. Tertiary structures of peptides were predicted using state-of-art method PEPstrMod. In order to assist users, a number of web-based tools have been integrated that includes keyword search, data browsing, similarity search and structural similarity. We believe that TopicalPdb is a unique database of its kind and it will be very useful in designing peptides for non-invasive topical delivery.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>Open Source Drug Discovery</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8902-2876</contrib-id>
          <name>
            <surname>Raghava</surname>
            <given-names>Gajendra P. S.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001332</institution-id>
            <institution>Council for Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GENESIS BSC0121</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8902-2876</contrib-id>
          <name>
            <surname>Raghava</surname>
            <given-names>Gajendra P. S.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001407</institution-id>
            <institution>Department of Biotechnology, Ministry of Science and Technology</institution>
          </institution-wrap>
        </funding-source>
        <award-id>project BTISNET</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8902-2876</contrib-id>
          <name>
            <surname>Raghava</surname>
            <given-names>Gajendra P. S.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award004">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Mathur</surname>
            <given-names>Deepika</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award005">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Mehta</surname>
            <given-names>Ayesha</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award006">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Firmal</surname>
            <given-names>Priyanka</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award007">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Bedi</surname>
            <given-names>Gursimran</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award008">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Sood</surname>
            <given-names>Charu</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award009">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001412</institution-id>
            <institution>Council of Scientific and Industrial Research</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <name>
            <surname>Gautam</surname>
            <given-names>Ankur</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>The authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug discovery and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="4"/>
      <table-count count="0"/>
      <page-count count="9"/>
    </counts>
    <custom-meta-group>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All data is available from the TopicalPdb database at URL <ext-link ext-link-type="uri" xlink:href="http://crdd.osdd.net/raghava/topicalpdb/">http://crdd.osdd.net/raghava/topicalpdb/</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All data is available from the TopicalPdb database at URL <ext-link ext-link-type="uri" xlink:href="http://crdd.osdd.net/raghava/topicalpdb/">http://crdd.osdd.net/raghava/topicalpdb/</ext-link>.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>Over the last decade, peptides have emerged as an important class of therapeutics for the treatment of many diseases like cancer, skin infections or autoimmune diseases due to their high specificity and potency[<xref rid="pone.0190134.ref001" ref-type="bibr">1</xref>]. In the year 2012 alone, six peptide-based drugs have been approved by food and drug administration (FDA), which reflects the potential of the peptides as a therapeutic entity[<xref rid="pone.0190134.ref002" ref-type="bibr">2</xref>]. Despite the significant potential of peptide-based drugs, one of the major concerns with these drugs is the route of administration, which has a significant impact on the therapeutic outcome of a drug.</p>
    <p>Peptide-based drugs are generally not administered orally because they are degraded extensively by proteases in the gastrointestinal (GI) tract before they reach circulation[<xref rid="pone.0190134.ref003" ref-type="bibr">3</xref>]. Though the parenteral route is the most common mode of administering these drugs and since it is a painful and invasive method, development of alternative non-invasive topical delivery formulations is the need of the hour. Therefore, considerable efforts have been made over the last few years to design and develop non-invasive and less painful routes for the administration of peptide-based drugs [<xref rid="pone.0190134.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0190134.ref005" ref-type="bibr">5</xref>]. Routes on which significant attention has been paid is the topical delivery through skin[<xref rid="pone.0190134.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0190134.ref007" ref-type="bibr">7</xref>], eyes [<xref rid="pone.0190134.ref008" ref-type="bibr">8</xref>], and nose[<xref rid="pone.0190134.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0190134.ref010" ref-type="bibr">10</xref>], which present attractive and convenient alternative as they by-pass the first pass hepatic metabolism. Since they are easy to use, non-invasive and painless, they provide better patient compliance.</p>
    <p>Topical delivery through skin looks very attractive, but at the same time, it is very challenging. The main obstacle in topical delivery through the skin is posed by the outermost dead layer of the epidermis <italic>i</italic>.<italic>e</italic>. stratum corneum (SC), which prevents molecules from diffusing readily[<xref rid="pone.0190134.ref007" ref-type="bibr">7</xref>]. Therefore, considerable efforts have been made to enhance the permeability of SC. Chemical modifications of peptides like the addition of lipophilic moieties produce analogs that show increased stability and skin permeability. Conjugation to CPPs and presence of enhancers in formulations has shown to enhance the penetration of peptides [<xref rid="pone.0190134.ref011" ref-type="bibr">11</xref>] through these topical routes.</p>
    <p>Transmucosal nasal drug delivery has also emerged as an important field of drug delivery technology[<xref rid="pone.0190134.ref012" ref-type="bibr">12</xref>]. Avoidance of hepatic first-pass metabolism, as well as high vascularity, and large surface area makes the transmucosal nasal drug delivery more attractive and popular. Over the last decade, a wide variety of peptide therapeutics has been administered intranasally for topical, systemic and central nervous system action [<xref rid="pone.0190134.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0190134.ref015" ref-type="bibr">15</xref>].</p>
    <p>Similarly, ocular delivery is another route of drug administration, which is increasing gaining scientific attention, as it is safe and non-invasive and may maintain drug levels in tissues[<xref rid="pone.0190134.ref016" ref-type="bibr">16</xref>]. However, drug delivery through the eye is very challenging and restricted by various precorneal, dynamic and static ocular barriers. In order to overcome these limitations, in the past, many novel formulations with peptides have been developed and evaluated[<xref rid="pone.0190134.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0190134.ref018" ref-type="bibr">18</xref>].</p>
    <p>Despite the significant importance of alternative non-invasive methods like topical delivery of peptides, to date, no heed has been paid to develop a dedicated repository of topically administered peptides. This information is very important but it is scattered in the literature and thus very difficult to access. In order to facilitate the scientific community engaged in developing peptide drug delivery, we have made an attempt to collect and compile all this scattered information related to topical delivery of peptides and developed a repository-TopicalPdb. TopicalPdb will be helpful for researchers working in the field of peptide therapeutics.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Methods</title>
    <sec id="sec003">
      <title>Data collection</title>
      <p>In order to provide comprehensive information on topically delivered peptides, we have performed a systematic search in PubMed using a combination of keywords- "topical[Title/Abstract] AND peptide[Title/Abstract]" and "peptide[Title/Abstract] AND penetrating[Title/Abstract] AND (skin[Title/Abstract] OR dermis[Title/Abstract] OR dermal[Title/Abstract] OR eye[Title/Abstract] OR ocular[Title/Abstract] OR nasal[Title/Abstract] OR nose[Title/Abstract])" in the query. These searches ended in around 1000 research articles as on July 2016 giving information of topically administered peptides, which include skin, eye, and nose. After careful readings, the information of such peptides like length, sequence, origin of peptides and other relevant experimental information like N-terminal modifications, C-terminal modifications, mechanisms, assay, assay conditions and tissue sample was collected manually from 135 articles. TopicalPdb finally contains total 657 entries.</p>
    </sec>
    <sec id="sec004">
      <title>Database architecture</title>
      <p>All the data was collected and compiled using MySQL. The database was launched using Apache HTTP server on Linux platform. We used HTML, PHP, JAVA to improve the web interface. Database architecture is shown <xref ref-type="fig" rid="pone.0190134.g001">Fig 1</xref>.</p>
      <fig id="pone.0190134.g001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0190134.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>Architecture of TopicalPdb.</title>
        </caption>
        <graphic xlink:href="pone.0190134.g001"/>
      </fig>
    </sec>
    <sec id="sec005">
      <title>Database content</title>
      <p>The primary information on topically delivered peptides was manually curated from research articles and consists of various fields such as PubMed ID, year, sequence, name of peptide, length, N-terminal modification, C-terminal modification, chirality, chemical modification, origin of peptide, biological property of peptide, mechanism, cargo sequence or structure, name of cargo, assay types, tissue permeability, incubation, concentration, <italic>in vivo</italic>/ in vitro/ <italic>ex vivo</italic> systems and tissue sample. All this information was compiled systematically. For a better understanding of the effect of experimental conditions on the permeation ability of the peptides, we made multiple entries of the same peptide if the permeability was studied under different conditions like change in pH of formulation, concentration of the peptide, cargo attached to the peptide, tissue sample used during the assay, etc.</p>
      <p>For the rational designing of topically administered peptides, it is imperative to understand their structure. In TopicalPdb, we have maintained the tertiary structure and SMILES of all peptide entries as secondary information. Firstly, all sequences were searched and mapped on PDB[<xref rid="pone.0190134.ref019" ref-type="bibr">19</xref>]. 58 exact sequence matches obtained were assigned structures as given in PDB. For peptides, whose identical sequences were not available in PDB, we used PEPstrMOD[<xref rid="pone.0190134.ref020" ref-type="bibr">20</xref>] to predict their structures. PEPstrMOD was used to predict the structure of 217 sequences of peptides with natural and modified residues with the length between 5 and 25. A total 69 peptide sequences had less than 5 residues and could not be predicted using PEPstrMOD. For such cases, dihedral angles were taken as 180. The structure obtained after energy minimization and molecular dynamic simulation was regarded as the final structure. The structures of natural peptides with length &gt;40 were assigned using I-TASSER[<xref rid="pone.0190134.ref021" ref-type="bibr">21</xref>]. Open Babel[<xref rid="pone.0190134.ref022" ref-type="bibr">22</xref>] was deployed for the conversion of 3D PDB structures to 2D SMILES notation.</p>
    </sec>
  </sec>
  <sec id="sec006">
    <title>Results and discussion</title>
    <sec id="sec007">
      <title>Implementation</title>
      <p>A user-friendly web-interface has been designed to query the database. For data searching and analysis, various tools have been integrated into the database. The brief description of these tools is as follows:</p>
      <sec id="sec008">
        <title>Searching tools</title>
        <p><underline>Simple search</underline>-This tool has been integrated to provide basic facility to search data from the database using a keyword (<xref ref-type="fig" rid="pone.0190134.g002">Fig 2</xref>). The users can perform a keyword search on any field of the database like PMID, name of the peptide, sequence of the peptide, assay, tissue sample and N- and C-terminal modifications. The users can select different fields to be displayed. The keyword should be without spaces.</p>
        <fig id="pone.0190134.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0190134.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Screenshots of simple search module of TopicalPdb.</title>
            <p><bold>(A)</bold> Simple search page allows users to search the database against a field of their choice, (B) result page of simple search, (C) Entry card with all fields of the peptide and (D) structure visualization of the peptide.</p>
          </caption>
          <graphic xlink:href="pone.0190134.g002"/>
        </fig>
        <p><underline>Compounded search</underline>- This option facilitates complex search to extract desired information from TopicalPdb. It has multiple query system, by default it allows one to perform four queries at a time; user can perform search on any selected field. Server provides facility to use standard logical operators (e.g., =, &gt;, &lt;, and LIKE). User can combine output of different queries using operators like “AND &amp; OR”. It also has option to add or remove queries to be executed.</p>
      </sec>
      <sec id="sec009">
        <title>Browsing tools</title>
        <p>We have developed a browsing facility, which facilitates retrieval of information in a classified form. A user-friendly interface has been integrated for browsing peptides on major field’s that include conformation, peptide length and route of administration. User can browse topically delivered peptides using these fields. In addition, user can browse peptides based on their chemical modifications like N-terminal, C-terminal modifications and non-terminal modifications.</p>
      </sec>
      <sec id="sec010">
        <title>Analysis tools</title>
        <p>TopicalPdb integrates various web-based tools for performing various analyses, like sequence similarity search, multiple sequence alignment, and structure alignment. We have integrated BLAST in TopicalPdb that allows users to perform BLAST search against peptides in the database. This allows users to identify topically delivered peptides in the database that have high sequence similarity with query peptide sequence. In addition to BLAST, we have also integrated another similarity search tools to perform sequence similarity based on Smith-Waterman algorithm. Peptide mapping tool allows users to identify peptides with the ability to be administered topically present within their proteins. The server searches such peptides and maps them on query protein submitted by the user. Multiple sequence alignment was implemented using HAlign[<xref rid="pone.0190134.ref023" ref-type="bibr">23</xref>]. HAlign employs parallel computing and center star strategy for fast and efficient alignment. Structural alignment was implemented using MUSCLE[<xref rid="pone.0190134.ref024" ref-type="bibr">24</xref>]. These alignment modules allow the users to align their query peptide sequence/structure with peptides present in TopicalPdb.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec011">
    <title>Statistics and analysis of TopicalPdb</title>
    <p>TopicalPdb consists of 657 entries of experimentally validated topically delivered peptides. In the current version, we have compiled peptides, which have been shown to deliver through the skin, eye, and nose. Maximum entries were made of peptides, which were delivered by skin (462 entries) followed by eye (173 entries) and nose (22 entries) (<xref ref-type="fig" rid="pone.0190134.g003">Fig 3A</xref>). In TopicalPdb, most of the peptides are linear (584 entries) while a few peptides are cyclic (73 entries) in nature as well. Since the stability of the peptides always remains a matter of concern while developing peptide-based therapeutics. Therefore, various strategies like chemical modification, terminal modifications, insertion of D-amino acids, etc. have been used in order to enhance the stability of peptide therapeutics. We have compiled the information of any such modifications in peptide since it is very important to the users. In TopicalPdb, maximum entries (553) of the peptide consisting of L-amino acids while there are 85 entries where peptides contain both L-and D-amino acids. Only 2 entries were compiled where peptide are completely D-amino acids. In addition, a total 152 entries were compiled where peptides are modified at N-terminus like acetylation and 172 entries give information of peptides, which are modified at C-terminus like amidation. Besides, a total 189 entries were compiled with information of any other chemical modification like non-natural amino acid (e.g., β-Alanine).</p>
    <fig id="pone.0190134.g003" orientation="portrait" position="float">
      <object-id pub-id-type="doi">10.1371/journal.pone.0190134.g003</object-id>
      <label>Fig 3</label>
      <caption>
        <p>Distribution of peptides on the basis of (A) route of administration, (B) assay condition and (C) length of peptide.</p>
      </caption>
      <graphic xlink:href="pone.0190134.g003"/>
    </fig>
    <p>Evaluation of skin-penetrating properties of peptides was carried out in different ways. Many peptides have been evaluated <italic>in vitro</italic> using Franz cell system as well as <italic>in vivo</italic> on mice skin. A few peptides have also been evaluated <italic>ex vivo</italic>. We have also compiled this information in TopicalPdb. A total 324 entries were compiled where peptide have been evaluated <italic>in vitro</italic>, while in 237 entries peptides were evaluated <italic>in vivo</italic>. A total 96 entries were made where peptides have been tested <italic>ex vivo</italic> (<xref ref-type="fig" rid="pone.0190134.g003">Fig 3B</xref>).</p>
    <p>We have also analyzed the length of such peptides, which have been demonstrated to be delivered topically. It was found that peptides ranging from length 5–50 have been delivered topically but average length of such peptides is between 5 and 15 as around 400 entries contain peptides having length between 5 and 15 (<xref ref-type="fig" rid="pone.0190134.g003">Fig 3C</xref>).</p>
    <p><xref ref-type="fig" rid="pone.0190134.g004">Fig 4</xref> shows the comparison of the amino acid composition of different types of topical peptides in respect to Swiss-Prot sequences. It was observed that compared to Swiss-Prot, topically delivered peptides are depleted in negatively charged amino acids D and E and aliphatic amino acids like I, L and V. Peptides administered topically by the dermal route were found to enriched in R and S, while those administered through the nose were rich in P and T whereas A, F, G and Y were found to be enriched in peptides delivered topically through the eye.</p>
    <fig id="pone.0190134.g004" orientation="portrait" position="float">
      <object-id pub-id-type="doi">10.1371/journal.pone.0190134.g004</object-id>
      <label>Fig 4</label>
      <caption>
        <title>Amino acid composition of Swiss-Prot sequences and topically administered peptides through skin, nose and eye.</title>
      </caption>
      <graphic xlink:href="pone.0190134.g004"/>
    </fig>
    <p>To the best of authors’ knowledge, TopicalPdb is the first dedicated database of peptides, which have been delivered topically through skin eye and nose. With the integration of several analysis and browsing tools, with the integration of several analysis and browsing tools, TopicalPdb is a very useful resource to the researchers in several ways: (i) TopicalPdb provides comprehensive information of peptides which can penetrate the skin; thus, users can use these peptides to develop novel formulations with the existing drugs in order to enhance the efficacy of the drugs. Interfaces like search and browse help the researchers to fetch all possible peptides based on their queries. (ii) TopicalPdb also provides the structural information of peptides. This structural information is very useful for researchers and it can be exploited for docking studies with skin proteins to understand if there is any interaction of these proteins with peptides. It has been reported previously that a few skin-penetrating peptides interact with the skin proteins like keratin and this initial interaction leads to penetration of these peptides into the skin. Using structure of these peptides, user can screen peptides available in the TopicalPdb for potential interactions with skin proteins. (iii) SC is the outermost layer of skin and is the biggest hurdle for any substance to enter into the skin. Most of the drugs cannot penetrate this skin barrier and thus their efficacy is severely reduced. Therefore, understanding the properties of these peptides which are enabling them to cross this dead layer of skin, will certainly be helpful for the development of future topically administered drugs. As shown in <xref ref-type="fig" rid="pone.0190134.g004">Fig 4</xref>, there are certain amino acids which are found to be dominated in topically delivered peptides compared to other peptides. Using the information of these residues and motifs which actually responsible for skin-penetrating properties, users can design novel peptide sequences as well as can tweak the existing peptides for superior activity. Therefore, in this context, TopicalPdb also provides datasets for the analysis and development of computational prediction methods of skin penetrating peptides.</p>
  </sec>
  <sec sec-type="conclusions" id="sec012">
    <title>Conclusion</title>
    <p>In summary, TopicalPdb is a much-needed platform of topically delivered peptides providing comprehensive information of the peptides which are delivered through skin, eye and nose. In addition, TopicalPdb also gives information of various chemical modifications as well as structural information of these peptides, which makes it a useful resource for the scientific community working in the field of topical delivery of peptides.</p>
  </sec>
  <sec id="sec013">
    <title>Limitations and update of TopicalPdb</title>
    <p>In TopicalPdb, we have stored the predicted tertiary structures of most of the topically delivered peptides, even the peptides with modified or non-natural amino acids. However, the structure of few peptides having complex modifications have not been predicted due to the lack of the force-field libraries for such kind of residue modifications. In the future, we will try to predict the structure of such peptides.</p>
    <p>One of the challenges in the field of database development is to update the information at regular intervals. Therefore, in this database, we have integrated an updating facility. Scientific community may submit TAPs to TopicalPdb using online submission form. Our team will update the information regularly from online submission as well as from literature.</p>
  </sec>
</body>
<back>
  <ack>
    <p>Authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug discovery and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India for financial support. Authors also thank Mr. Sandeep Singh for helping in the structure prediction of peptides.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pone.0190134.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Fosgerau</surname><given-names>K</given-names></name>, <name><surname>Hoffmann</surname><given-names>T</given-names></name>. <article-title>Peptide therapeutics: current status and future directions</article-title>. <source>Drug Discov Today</source>. <year>2015</year>;<volume>20</volume>(<issue>1</issue>):<fpage>122</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.drudis.2014.10.003">10.1016/j.drudis.2014.10.003</ext-link></comment> .<?supplied-pmid 25450771?><pub-id pub-id-type="pmid">25450771</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Kaspar</surname><given-names>AA</given-names></name>, <name><surname>Reichert</surname><given-names>JM</given-names></name>. <article-title>Future directions for peptide therapeutics development</article-title>. <source>Drug Discov Today</source>. <year>2013</year>;<volume>18</volume>(<issue>17–18</issue>):<fpage>807</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.drudis.2013.05.011">10.1016/j.drudis.2013.05.011</ext-link></comment> .<?supplied-pmid 23726889?><pub-id pub-id-type="pmid">23726889</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Bruno</surname><given-names>BJ</given-names></name>, <name><surname>Miller</surname><given-names>GD</given-names></name>, <name><surname>Lim</surname><given-names>CS</given-names></name>. <article-title>Basics and recent advances in peptide and protein drug delivery</article-title>. <source>Ther Deliv</source>. <year>2013</year>;<volume>4</volume>(<issue>11</issue>):<fpage>1443</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4155/tde.13.104">10.4155/tde.13.104</ext-link></comment> ; PubMed Central PMCID: PMC3956587.<?supplied-pmid 24228993?><pub-id pub-id-type="pmid">24228993</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Witting</surname><given-names>M</given-names></name>, <name><surname>Obst</surname><given-names>K</given-names></name>, <name><surname>Friess</surname><given-names>W</given-names></name>, <name><surname>Hedtrich</surname><given-names>S</given-names></name>. <article-title>Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers</article-title>. <source>Biotechnol Adv</source>. <year>2015</year>;<volume>33</volume>(<issue>6 Pt 3</issue>):<fpage>1355</fpage>–<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biotechadv.2015.01.010">10.1016/j.biotechadv.2015.01.010</ext-link></comment> .<?supplied-pmid 25687276?><pub-id pub-id-type="pmid">25687276</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Jitendra</surname><given-names>Sharma PK</given-names></name>, <name><surname>Bansal</surname><given-names>S</given-names></name>, <name><surname>Banik</surname><given-names>A</given-names></name>. <article-title>Noninvasive routes of proteins and peptides drug delivery</article-title>. <source>Indian J Pharm Sci</source>. <year>2011</year>;<volume>73</volume>(<issue>4</issue>):<fpage>367</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4103/0250-474X.95608">10.4103/0250-474X.95608</ext-link></comment> ; PubMed Central PMCID: PMC3374550.<?supplied-pmid 22707818?><pub-id pub-id-type="pmid">22707818</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Lopes</surname><given-names>LB</given-names></name>, <name><surname>Carvalho</surname><given-names>VF</given-names></name>, <name><surname>de Lemos</surname><given-names>DP</given-names></name>. <article-title>Potential of peptide-based enhancers for transdermal delivery</article-title>. <source>Curr Pharm Des</source>. <year>2015</year>;<volume>21</volume>(<issue>20</issue>):<fpage>2814</fpage>–<lpage>22</lpage>. .<?supplied-pmid 25925116?><pub-id pub-id-type="pmid">25925116</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Nasrollahi</surname><given-names>SA</given-names></name>, <name><surname>Taghibiglou</surname><given-names>C</given-names></name>, <name><surname>Azizi</surname><given-names>E</given-names></name>, <name><surname>Farboud</surname><given-names>ES</given-names></name>. <article-title>Cell-penetrating peptides as a novel transdermal drug delivery system</article-title>. <source>Chem Biol Drug Des</source>. <year>2012</year>;<volume>80</volume>(<issue>5</issue>):<fpage>639</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cbdd.12008">10.1111/cbdd.12008</ext-link></comment> .<?supplied-pmid 22846609?><pub-id pub-id-type="pmid">22846609</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Pescina</surname><given-names>S</given-names></name>, <name><surname>Sala</surname><given-names>M</given-names></name>, <name><surname>Padula</surname><given-names>C</given-names></name>, <name><surname>Scala</surname><given-names>MC</given-names></name>, <name><surname>Spensiero</surname><given-names>A</given-names></name>, <name><surname>Belletti</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Design and Synthesis of New Cell Penetrating Peptides: Diffusion and Distribution Inside the Cornea</article-title>. <source>Mol Pharm</source>. <year>2016</year>;<volume>13</volume>(<issue>11</issue>):<fpage>3876</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.molpharmaceut.6b00658">10.1021/acs.molpharmaceut.6b00658</ext-link></comment> .<?supplied-pmid 27676095?><pub-id pub-id-type="pmid">27676095</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Campbell</surname><given-names>C</given-names></name>, <name><surname>Morimoto</surname><given-names>BH</given-names></name>, <name><surname>Nenciu</surname><given-names>D</given-names></name>, <name><surname>Fox</surname><given-names>AW</given-names></name>. <article-title>Drug development of intranasally delivered peptides</article-title>. <source>Ther Deliv</source>. <year>2012</year>;<volume>3</volume>(<issue>4</issue>):<fpage>557</fpage>–<lpage>68</lpage>. .<?supplied-pmid 22834082?><pub-id pub-id-type="pmid">22834082</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Meredith</surname><given-names>ME</given-names></name>, <name><surname>Salameh</surname><given-names>TS</given-names></name>, <name><surname>Banks</surname><given-names>WA</given-names></name>. <article-title>Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases</article-title>. <source>AAPS J</source>. <year>2015</year>;<volume>17</volume>(<issue>4</issue>):<fpage>780</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1208/s12248-015-9719-7">10.1208/s12248-015-9719-7</ext-link></comment> ; PubMed Central PMCID: PMC4476983.<?supplied-pmid 25801717?><pub-id pub-id-type="pmid">25801717</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Lopes</surname><given-names>LB</given-names></name>, <name><surname>Brophy</surname><given-names>CM</given-names></name>, <name><surname>Furnish</surname><given-names>E</given-names></name>, <name><surname>Flynn</surname><given-names>CR</given-names></name>, <name><surname>Sparks</surname><given-names>O</given-names></name>, <name><surname>Komalavilas</surname><given-names>P</given-names></name>, <etal>et al</etal><article-title>Comparative study of the skin penetration of protein transduction domains and a conjugated peptide</article-title>. <source>Pharm Res</source>. <year>2005</year>;<volume>22</volume>(<issue>5</issue>):<fpage>750</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11095-005-2591-x">10.1007/s11095-005-2591-x</ext-link></comment> .<?supplied-pmid 15906170?><pub-id pub-id-type="pmid">15906170</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Fortuna</surname><given-names>A</given-names></name>, <name><surname>Alves</surname><given-names>G</given-names></name>, <name><surname>Serralheiro</surname><given-names>A</given-names></name>, <name><surname>Sousa</surname><given-names>J</given-names></name>, <name><surname>Falcao</surname><given-names>A</given-names></name>. <article-title>Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules</article-title>. <source>Eur J Pharm Biopharm</source>. <year>2014</year>;<volume>88</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejpb.2014.03.004">10.1016/j.ejpb.2014.03.004</ext-link></comment> .<?supplied-pmid 24681294?><pub-id pub-id-type="pmid">24681294</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>E</given-names></name>, <name><surname>He</surname><given-names>H</given-names></name>, <name><surname>Shin</surname><given-names>MC</given-names></name>, <name><surname>Moon</surname><given-names>C</given-names></name>, <name><surname>Yang</surname><given-names>VC</given-names></name>, <etal>et al</etal><article-title>Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides</article-title>. <source>Acta Pharm Sin B</source>. <year>2016</year>;<volume>6</volume>(<issue>4</issue>):<fpage>352</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.apsb.2016.04.001">10.1016/j.apsb.2016.04.001</ext-link></comment> ; PubMed Central PMCID: PMCPMC4951590.<?supplied-pmid 27471676?><pub-id pub-id-type="pmid">27471676</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Kamei</surname><given-names>N</given-names></name>, <name><surname>Takeda-Morishita</surname><given-names>M</given-names></name>. <article-title>Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides</article-title>. <source>J Control Release</source>. <year>2015</year>;<volume>197</volume>:<fpage>105</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jconrel.2014.11.004">10.1016/j.jconrel.2014.11.004</ext-link></comment> .<?supplied-pmid 25445695?><pub-id pub-id-type="pmid">25445695</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Gill</surname><given-names>JC</given-names></name>, <name><surname>Ottum</surname><given-names>M</given-names></name>, <name><surname>Schwartz</surname><given-names>B</given-names></name>. <article-title>Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease</article-title>. <source>J Pediatr</source>. <year>2002</year>;<volume>140</volume>(<issue>5</issue>):<fpage>595</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1067/mpd.2002.123626">10.1067/mpd.2002.123626</ext-link></comment> .<?supplied-pmid 12032528?><pub-id pub-id-type="pmid">12032528</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Yavuz</surname><given-names>B</given-names></name>, <name><surname>Kompella</surname><given-names>UB</given-names></name>. <article-title>Ocular Drug Delivery</article-title>. <source>Handb Exp Pharmacol</source>. <year>2016</year><comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/164_2016_84">10.1007/164_2016_84</ext-link></comment> .<?supplied-pmid 27783270?><pub-id pub-id-type="pmid">27783270</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Gilbard</surname><given-names>JP</given-names></name>, <name><surname>Rossi</surname><given-names>SR</given-names></name>, <name><surname>Heyda</surname><given-names>KG</given-names></name>, <name><surname>Dartt</surname><given-names>DA</given-names></name>. <article-title>Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>1990</year>;<volume>31</volume>(<issue>7</issue>):<fpage>1381</fpage>–<lpage>8</lpage>. .<?supplied-pmid 2365569?><pub-id pub-id-type="pmid">2365569</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Krootila</surname><given-names>K</given-names></name>. <article-title>CGRP in relation to neurogenic inflammation and cAMP in the rabbit eye</article-title>. <source>Exp Eye Res</source>. <year>1988</year>;<volume>47</volume>(<issue>2</issue>):<fpage>307</fpage>–<lpage>16</lpage>. .<?supplied-pmid 2842178?><pub-id pub-id-type="pmid">2842178</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Rose</surname><given-names>PW</given-names></name>, <name><surname>Prlic</surname><given-names>A</given-names></name>, <name><surname>Bi</surname><given-names>C</given-names></name>, <name><surname>Bluhm</surname><given-names>WF</given-names></name>, <name><surname>Christie</surname><given-names>CH</given-names></name>, <name><surname>Dutta</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>The RCSB Protein Data Bank: views of structural biology for basic and applied research and education</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>(Database issue):<fpage>D345</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gku1214">10.1093/nar/gku1214</ext-link></comment> ; PubMed Central PMCID: PMC4383988.<?supplied-pmid 25428375?><pub-id pub-id-type="pmid">25428375</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>S</given-names></name>, <name><surname>Singh</surname><given-names>H</given-names></name>, <name><surname>Tuknait</surname><given-names>A</given-names></name>, <name><surname>Chaudhary</surname><given-names>K</given-names></name>, <name><surname>Singh</surname><given-names>B</given-names></name>, <name><surname>Kumaran</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues</article-title>. <source>Biol Direct</source>. <year>2015</year>;<volume>10</volume>:<fpage>73</fpage><comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13062-015-0103-4">10.1186/s13062-015-0103-4</ext-link></comment> ; PubMed Central PMCID: PMC4687368.<?supplied-pmid 26690490?><pub-id pub-id-type="pmid">26690490</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>R</given-names></name>, <name><surname>Roy</surname><given-names>A</given-names></name>, <name><surname>Xu</surname><given-names>D</given-names></name>, <name><surname>Poisson</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>. <article-title>The I-TASSER Suite: protein structure and function prediction</article-title>. <source>Nat Methods</source>. <year>2015</year>;<volume>12</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth.3213">10.1038/nmeth.3213</ext-link></comment> ; PubMed Central PMCID: PMC4428668.<?supplied-pmid 25549265?><pub-id pub-id-type="pmid">25549265</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>O'Boyle</surname><given-names>NM</given-names></name>, <name><surname>Banck</surname><given-names>M</given-names></name>, <name><surname>James</surname><given-names>CA</given-names></name>, <name><surname>Morley</surname><given-names>C</given-names></name>, <name><surname>Vandermeersch</surname><given-names>T</given-names></name>, <name><surname>Hutchison</surname><given-names>GR</given-names></name>. <article-title>Open Babel: An open chemical toolbox</article-title>. <source>J Cheminform</source>. <year>2011</year>;<volume>3</volume>:<fpage>33</fpage><comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1758-2946-3-33">10.1186/1758-2946-3-33</ext-link></comment> ; PubMed Central PMCID: PMC3198950.<?supplied-pmid 21982300?><pub-id pub-id-type="pmid">21982300</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>Q</given-names></name>, <name><surname>Hu</surname><given-names>Q</given-names></name>, <name><surname>Guo</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>. <article-title>HAlign: Fast multiple similar DNA/RNA sequence alignment based on the centre star strategy</article-title>. <source>Bioinformatics</source>. <year>2015</year>;<volume>31</volume>(<issue>15</issue>):<fpage>2475</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btv177">10.1093/bioinformatics/btv177</ext-link></comment> .<?supplied-pmid 25812743?><pub-id pub-id-type="pmid">25812743</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0190134.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Edgar</surname><given-names>RC</given-names></name>. <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>(<issue>5</issue>):<fpage>1792</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkh340">10.1093/nar/gkh340</ext-link></comment> ; PubMed Central PMCID: PMC390337.<?supplied-pmid 15034147?><pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
